SYRE Spyre Therapeutics, Inc.

NASDAQ

$80.10

Spyre Therapeutics, Inc. (SYRE) Earnings News

Earnings press releases, previews and reviews for Spyre Therapeutics, Inc. (SYRE), newest first.

Tuesday August 4, 2026 4:02 PM ET

Spyre Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Tuesday May 5, 2026 8:00 AM ET

Spyre Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update